Phase 1 studies of central memory–derived CD19 CAR T–cell therapy following autologous HSCT in patients with B-cell NHL

Wang X, Popplewell L, Wagner J, Naranjo A, Blanchard M, Mott M, Norris A, Wong C, Urak R, Chang W, Khaled S, Siddiqi T, Budde L, Xu J, Chang B, Gidwaney N, Thomas S, Cooper L, Riddell S, Brown C, Jensen M, Forman S. Phase 1 studies of central memory–derived CD19 CAR T–cell therapy following autologous HSCT in patients with B-cell NHL. BLOOD, 16 JUNE 2016 x VOLUME 127, NUMBER 24. DOI 10.1182/blood-2015-12-686725

Date

BioLife Solutions Symbol

This website uses cookies to ensure you get the best experience on our website.